BOB KURTS: Open Payments
NPI 1033144712 · PARADISE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 83 payments from 22 companies in 2025. Trend: 2023 $603 · 2024 $1,330 · 2025 $2,009
Food & beverage: $2,009
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $421 |
| PFIZER INC. | 12 | $272 |
| AstraZeneca Pharmaceuticals LP | 6 | $255 |
| Amgen Inc. | 7 | $152 |
| Lilly USA, LLC | 4 | $136 |
| Daiichi Sankyo Inc. | 4 | $109 |
| Novo Nordisk Inc | 4 | $87 |
| Dexcom, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
Products named: VRAYLAR, AIRSUPRA, BREZTRI, COMIRNATY, UBRELVY, EVENITY, INJECTAFER, JARDIANCE.
Industry payments across CA — which companies pay providers there.
